Khan Nafia F, Salim Malinda, Binte Abu Bakar Syaza Y, Ristroph Kurt, Prud'homme Robert K, Hawley Adrian, Boyd Ben J, Clulow Andrew J
UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.
Int J Pharm X. 2022 Feb 9;4:100113. doi: 10.1016/j.ijpx.2022.100113. eCollection 2022 Dec.
Lipid-based formulations improve the absorption capacity of poorly-water-soluble drugs and digestion of the formulation is a critical step in that absorption process. A recent approach to understanding the propensity for drug to dissolve in digesting lipid-based formulations couples an pH-stat lipolysis model to small-angle X-ray scattering (SAXS) by means of a flow-through capillary. However, the conventional pH-stat apparatus used to measure the extent of lipid digestion during such experiments requires digest volumes of 15-30 mL and drug doses of 50-200 mg, which is problematic for scarce compounds and can require excessive amounts of formulation reagents. This manuscript describes an approach to reduce the amount of material required for lipolysis experiments coupled to SAXS, for use in instances where the amount of drug or formulation medium is limited. Importantly, this was achieved while maintaining the pH stat conditions, which is critical for maintaining biorelevance and driving digestion to completion. The digestibility of infant formula with the poorly-water-soluble drugs halofantrine and clofazimine dispersed into it was measured as an exemplar paediatric-friendly lipid formulation. Halofantrine was incorporated in its powdered free base form and clofazimine was incorporated both as unformulated drug powder and as drug in nanoparticulate form prepared using Flash NanoPrecipitation. The fraction of triglyceride digested was found to be independent of vessel size and the incorporation of drug. The dissolution of the two forms of clofazimine during the digestion of infant formula were then measured using synchrotron SAXS, which revealed complete and partial solubilisation over 30 min of digestion for the powdered drug and nanoparticle formulations, respectively. The main challenge in reducing the volume of the measurements was in ensuring that thorough mixing was occurring in the smaller digestion vessel to provide uniform sampling of the dispersion medium.
基于脂质的制剂可提高难溶性药物的吸收能力,而制剂的消化是该吸收过程中的关键步骤。最近,一种用于理解药物在消化的脂质基制剂中溶解倾向的方法,是通过流通毛细管将pH计脂肪分解模型与小角X射线散射(SAXS)相结合。然而,在这类实验中用于测量脂质消化程度的传统pH计装置需要15 - 30毫升的消化体积和50 - 200毫克的药物剂量,这对于稀缺化合物来说是个问题,并且可能需要过量的制剂试剂。本手稿描述了一种减少与SAXS联用的脂肪分解实验所需材料量的方法,用于药物或制剂介质量有限的情况。重要的是,这是在保持pH计条件的同时实现的,这对于维持生物相关性和推动消化完成至关重要。作为一种适合儿科的脂质制剂示例,测定了分散有难溶性药物卤泛群和氯法齐明的婴儿配方奶粉的消化率。卤泛群以其游离碱粉末形式加入,氯法齐明既以未配制的药物粉末形式加入,也以使用快速纳米沉淀法制备的纳米颗粒形式的药物加入。发现甘油三酯消化的比例与容器大小和药物加入无关。然后使用同步加速器SAXS测量了婴儿配方奶粉消化过程中两种形式氯法齐明的溶解情况,结果显示,对于粉末状药物和纳米颗粒制剂,在30分钟的消化过程中分别实现了完全和部分溶解。减少测量体积的主要挑战在于确保在较小的消化容器中发生充分混合,以便对分散介质进行均匀采样。